The STop UNhealthy Substance Use Now Trial
- Conditions
- Substance Use DisordersAlcohol Use DisorderDrinking, AlcoholRisky Health BehaviorSubstance UseSubstance Abuse
- Interventions
- Other: Practice Facilitation (PF)Other: Performance Incentives (PI)Other: Learning Collaborative (LC)
- Registration Number
- NCT06524232
- Lead Sponsor
- Ohio State University
- Brief Summary
The STop UNhealthy (STUN) Substance Use Now Trial (STUN II) is a multisite trial aiming to evaluate the comparative effectiveness of the following strategies for improving the implementation of screening and interventions for substance use disorders in primary care: practice facilitation (PF), PF plus a learning collaborative (LC), PF plus performance incentives (PI), and PF+LC+PI. We plan to enroll 144 clinic staff participants from 48 primary care practices
- Detailed Description
The STop UNhealthy (STUN) Substance Use Now Trial (STUN II) is a multisite trial aiming to evaluate the comparative effectiveness of the following strategies for improving the implementation of screening and interventions for substance use disorders in primary care: practice facilitation (PF), PF plus a learning collaborative (LC), PF plus performance incentives (PI), and PF+LC+PI. We plan to enroll 144 clinic staff participants from 48 primary care practices
Specific aim 1 (primary aim) will compare the effect of learning collaborative (LC) participation, performance incentives (PI), or their combination, with practice facilitation (PF) only, on implementation of evidence-based screening for SUDs.
Specific aim 2 (secondary aim) will compare the effect of LC participation, PI, or their combination, with PF only, on implementation of evidence-based interventions for SUDs, including (a) brief counseling, (b) medications (e.g., buprenorphine, naltrexone) and adherence to them, and (c) referral to specialty care.
Specific aims 1 and 2 will produce fundamentally important evidence about the comparative effectiveness of PF, PF+LC, PF+PI, and PF+LC+PI strategies on uptake of evidence-based screening and interventions for SUD when delivered to primary care practices.
Specific aim 3 (exploratory aim) will use a longitudinal mixed-methods evaluation to assess the association between implementation effectiveness and putative moderators (e.g., organizational readiness for change) and mediators (e.g., implementation climate). Aim 3 will generate scientific knowledge about mechanisms of change (why and how the various strategies work) in primary care settings.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 144
- Clinic staff members from primary care practices who provide care for adult patients and have a leadership role within the practice (e.g. lead physician, practice manager, lead medical assistant/nurse, clinical champion)
- Clinic staff members who already have ongoing involvement in programs that would conflict with or preclude this study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Practice Facilitation + Learning Collaborative Practice Facilitation (PF) Practice Facilitation (PF): Practices will receive up to 2 hours of direct practice facilitation services per month for 12 months. Learning Collaborative (LC): Virtual LC sessions will be held monthly and will include participants presenting anonymized cases to clinical experts, targeted brief didactics related to the content of the cases, and time for open discussion and Q\&A. Practice Facilitation + Performance Incentives Performance Incentives (PI) Practice Facilitation: Practices will receive up to 2 hours of direct practice facilitation services per month for 12 months. Performance Incentives: Practices will receive a maximum total of $6,000 based on their performance during the 12-month implementation period. They will have the opportunity to receive up to $1,500 per quarter if they reach performance milestones for the quarter. Practice Facilitation Only Practice Facilitation (PF) Practice Facilitation: Practices will receive up to 2 hours of direct practice facilitation services per month for 12 months. Practice Facilitation + Learning Collaborative Learning Collaborative (LC) Practice Facilitation (PF): Practices will receive up to 2 hours of direct practice facilitation services per month for 12 months. Learning Collaborative (LC): Virtual LC sessions will be held monthly and will include participants presenting anonymized cases to clinical experts, targeted brief didactics related to the content of the cases, and time for open discussion and Q\&A. Practice Facilitation + Performance Incentives Practice Facilitation (PF) Practice Facilitation: Practices will receive up to 2 hours of direct practice facilitation services per month for 12 months. Performance Incentives: Practices will receive a maximum total of $6,000 based on their performance during the 12-month implementation period. They will have the opportunity to receive up to $1,500 per quarter if they reach performance milestones for the quarter. Practice Facilitation + Learning Collaborative + Performance Incentives Practice Facilitation (PF) Practice Facilitation: Practices will receive up to 2 hours of direct practice facilitation services per month for 12 months. Learning Collaborative (LC): Virtual LC sessions will be held monthly and will include participants presenting anonymized cases to clinical experts, targeted brief didactics related to the content of the cases, and time for open discussion and Q\&A. Performance Incentives: Practices will receive a maximum total of $6,000 based on their performance during the 12-month implementation period. They will have the opportunity to receive up to $1,500 per quarter if they reach performance milestones for the quarter. Practice Facilitation + Learning Collaborative + Performance Incentives Performance Incentives (PI) Practice Facilitation: Practices will receive up to 2 hours of direct practice facilitation services per month for 12 months. Learning Collaborative (LC): Virtual LC sessions will be held monthly and will include participants presenting anonymized cases to clinical experts, targeted brief didactics related to the content of the cases, and time for open discussion and Q\&A. Performance Incentives: Practices will receive a maximum total of $6,000 based on their performance during the 12-month implementation period. They will have the opportunity to receive up to $1,500 per quarter if they reach performance milestones for the quarter. Practice Facilitation + Learning Collaborative + Performance Incentives Learning Collaborative (LC) Practice Facilitation: Practices will receive up to 2 hours of direct practice facilitation services per month for 12 months. Learning Collaborative (LC): Virtual LC sessions will be held monthly and will include participants presenting anonymized cases to clinical experts, targeted brief didactics related to the content of the cases, and time for open discussion and Q\&A. Performance Incentives: Practices will receive a maximum total of $6,000 based on their performance during the 12-month implementation period. They will have the opportunity to receive up to $1,500 per quarter if they reach performance milestones for the quarter.
- Primary Outcome Measures
Name Time Method Number of adults screened for substance use disorder 12 months Number of people aged 18 and older who are screened for substance use disorder using a validated screening tool
Percent of adults screened for substance use disorder 12 months Percent of people aged 18 and older who are screened for substance use disorder using a validated screening tool
- Secondary Outcome Measures
Name Time Method Percentage of adults who received medication for substance use disorder, including alcohol use disorder 12 months Of people aged 18 or older who screened positive for substance use disorder and/or alcohol use disorder, percentage who received medication
Number of adults who received medication for substance use disorder, including alcohol use disorder, and adhered to 6 months of treatment 24 months Of those aged 18 or older who received medication for substance use disorder and/or alcohol use disorder, number who adhered to treatment for 6 months
Percentage of adults who received medication for substance use disorder, including alcohol use disorder, and adhered to 6 months of treatment 12 months Of those aged 18 or older who received medication for substance use disorder and/or alcohol use disorder, percentage who adhered to treatment for 6 months
Percent of adults with a positive screen for substance use disorder 24 months Of those aged 18 and older who were screened for substance use disorder, percentage who had a positive screening result
Number of adults with a positive screen for substance use disorder 24 months Of those aged 18 and older who were screened for substance use disorder, number who had a positive screening result
Percentage of adults who received medication for substance use disorder 24 months Of people aged 18 or older who screened positive for substance use disorder and/or alcohol use disorder, percentage who received medication
Number of adults who received any evidence-based intervention for alcohol use disorder 24 months Of those aged 18 or older identified as having alcohol use disorder, number who received any evidence-based intervention (brief counseling, medication, referral to specialty care)
Number of adults who received medication for alcohol use disorder 24 months Of those aged 18 or older identified as having alcohol use disorder, number who received medication
Percentage of adults who received medication for alcohol use disorder 12 months Of those aged 18 or older identified as having alcohol use disorder, percentage who received medication
Percentage of adults who received medication for alcohol use disorder and adhered to 6 months of treatment 12 months Of those aged 18 or older who received medication for alcohol use disorder, percentage who adhered to treatment for 6 months
Number of adults referred to specialty care for alcohol use disorder 24 months Of those aged 18 or older who were identified as having alcohol use disorder, number who were referred to specialty care (psychiatry, 12-step programs, counseling, etc.)
Number of adults screened for substance use disorder 24 months Number of people aged 18 and older who are screened for substance use disorder using a validated screening tool
Percent of adults screened for substance use disorder 24 months Percent of people aged 18 and older who are screened for substance use disorder using a validated screening tool
Number of adults who received any evidence-based intervention for substance use disorder 24 months Of those aged 18 or older who were identified as having substance use disorder and/or alcohol use disorder, number who received brief counseling, medication, or referral to specialty care
Number of adults who received medication for substance use disorder 24 months Of people aged 18 or older who screened positive for substance use disorder and/or alcohol use disorder, number who received medication
Number of adults who received medication for alcohol use disorder and adhered to 6 months of treatment 24 months Of those aged 18 or older who received medication for alcohol use disorder, number who adhered to treatment for 6 months
Percentage of adults who received any evidence-based intervention for substance use disorder 12 months Of those aged 18 or older who were identified as having substance use disorder and/or alcohol use disorder, percentage that received brief counseling, medication, or referral to specialty care
Number of adults who received brief counseling for substance use disorder 24 months Of people aged 18 or older who screened positive for substance use disorder and/or alcohol use disorder, number who received brief counseling
Percentage of adults who received brief counseling for substance use disorder 12 months Of people aged 18 or older who screened positive for substance use disorder and/or alcohol use disorder, percentage who received brief counseling
Number of adults referred to specialty care for substance use disorder and/or alcohol use disorder 24 months Of those aged 18 or older who were identified as having substance use disorder and/or alcohol use disorder, number who were referred to specialty care (psychiatry, 12-step programs, counseling, etc.)
Percentage of adults referred to specialty care for substance use disorder and/or alcohol use disorder 12 months Of those aged 18 or older who were identified as having substance use disorder and/or alcohol use disorder, percentage who were referred to specialty care (psychiatry, 12-step programs, counseling, etc.)
Number of adults with alcohol use disorder 24 months Of those aged 18 or older who were screened for substance use disorder, number who had alcohol use disorder
Percentage of adults with alcohol use disorder 12 months Of those aged 18 or older who were screened for substance use disorder, percentage who had alcohol use disorder
Percentage of adults who received any evidence-based intervention for alcohol use disorder 12 months Of those aged 18 or older identified as having alcohol use disorder, percentage who received any evidence-based intervention (brief counseling, medication, referral to specialty care)
Percentage of adults referred to specialty care for alcohol use disorder 12 months Of those aged 18 or older who were identified as having alcohol use disorder, percentage who were referred to specialty care (psychiatry, 12-step programs, counseling, etc.)
Number of adults who received brief counseling for alcohol use disorder 24 months Of those aged 18 or older identified as having alcohol use disorder, number who received brief counseling
Percentage of adults who received brief counseling for alcohol use disorder 12 months Of those aged 18 or older identified as having alcohol use disorder, percentage who received brief counseling
Trial Locations
- Locations (3)
Bon Secours Mercy Health
🇺🇸Cincinnati, Ohio, United States
The Ohio State University Wexner Medical Center
🇺🇸Columbus, Ohio, United States
Ohio Association of Community Health Centers
🇺🇸Columbus, Ohio, United States
Bon Secours Mercy Health🇺🇸Cincinnati, Ohio, United StatesWilliam FelkelContact